Me CEO Anne Wojcicki continues to maintain a strong outlook despite recent high-profile stumbles. “We are a long-term company ...
Once worth $6 billion, 23andMe has lost 98% of its value and is on the verge of being delisted from the Nasdaq. So what ...
As a result, the start-up lost a lot of value. In September, the company parted ways with all board members with the ...
She was 28. Brin was 40 and amicably separated from his wife, health entrepreneur Anne Wojcicki, who had discovered his ...
In this podcast, Motley Fool analyst Jason Moser and host Mary Long discuss the semiconductor supply chain, ASML's earnings, ...
The entire board of DNA testing company 23andMe resigned after a conflict with CEO Anne Wojcicki over her plan to take the ...
Consumer DNA testing company 23andMe is circling the drain. The company's CEO, Anne Wojcicki, plans to take the company ...
With 23andme in a desperate situation and eyeing a potential sale, Medical Device Network examines what is set to happen to ...
Over the past year, 23andMe set new corporate governance lows. CEO Anne Wojcicki now enters de facto “founder mode” after a ...
Turmoil at 23andMe, and a lawsuit alleging that GEDmatch shares data with Facebook, highlights how far your genetic ...
Anne Wojcicki, Eren Bali, Jay Desai, Nish Bhat, Matt Mochary, and others. To learn more, visit ambiencehealthcare.com. KLAS is a research and insights firm on a global mission to improve healthcare ...
Me helped usher in the era of consumer DNA test kits nearly two decades ago, but has more recently faced a series of setbacks ...